Landmark trial
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
Murthy V, Maitre P, Kannan S, et al.
DoseLab summary
Efficacy results of the POP-RT randomized phase 3 trial. Citation as given in the eviQ reference list; not yet checked against the journal.
Why this is useful
Phase 3 trial comparing prostate-only with whole-pelvic radiotherapy in high-risk prostate cancer — key modern evidence on elective nodal treatment.
Reference details
- Title
- Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
- Authors / organization
- Murthy V, Maitre P, Kannan S, et al.
- Publication / protocol
- J Clin Oncol. 2021;39(11):1234–1242
- Version
- Pending verification
- Year
- 2021
- DOI
- Pending verification
- Disease sites
- Prostate
- Topics
- Prostate, Pelvic nodes, Landmark trial
- Fractionation context
- Prostate only vs whole pelvis
- Last reviewed by DoseLab
- Pending verification